Curtis R. Brandt - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Microbiology Biology

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kolb AW, Ferguson SA, Larsen IV, Brandt CR. Disease parameters following ocular herpes simplex virus type 1 infection are similar in male and female BALB/C mice. Plos One. 18: e0287194. PMID 37319284 DOI: 10.1371/journal.pone.0287194  0.339
2023 Hiscott J, Brandt CR. Editorial: Insights in virus and host: 2021. Frontiers in Cellular and Infection Microbiology. 13: 1190338. PMID 37113129 DOI: 10.3389/fcimb.2023.1190338  0.365
2020 Kolb AW, Brandt CR. Genomic nucleotide-based distance analysis for delimiting old world monkey derived herpes simplex virus species. Bmc Genomics. 21: 436. PMID 32590937 DOI: 10.1186/S12864-020-06847-W  0.402
2018 Lewin AC, Kolb AW, McLellan GJ, Bentley E, Bernard KA, Newbury SP, Brandt CR. Genomic, Recombinational and Phylogenetic Characterization of Global Feline Herpesvirus 1 Isolates. Virology. 518: 385-397. PMID 29605685 DOI: 10.1016/J.Virol.2018.03.018  0.333
2018 Aktas Z, Rao H, Slauson SR, Gabelt BT, Larsen IV, Sheridan RTC, Herrnberger L, Tamm ER, Kaufman PL, Brandt CR. Proteasome Inhibition Increases the Efficiency of Lentiviral Vector-Mediated Transduction of Trabecular Meshwork. Investigative Ophthalmology & Visual Science. 59: 298-310. PMID 29340644 DOI: 10.1167/Iovs.17-22074  0.309
2016 Lee K, Kolb AW, Larsen I, Craven M, Brandt CR. Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the HSV-1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US Regions. Journal of Virology. PMID 27384650 DOI: 10.1128/Jvi.00821-16  0.357
2016 Larsen IV, Clausius H, Kolb AW, Brandt CR. Both CD8+ and CD4+ T-Cells Contribute to Corneal Clouding and Viral Clearance Following Vaccinia Virus Infection in C57BL/6 Mice. Journal of Virology. PMID 27170749 DOI: 10.1128/Jvi.00570-16  0.455
2016 Kolb AW, Lee K, Larsen I, Craven M, Brandt CR. Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence. Plos Pathogens. 12: e1005499. PMID 26962864 DOI: 10.1371/Journal.Ppat.1005499  0.373
2015 Lee K, Kolb AW, Sverchkov Y, Cuellar JA, Craven M, Brandt CR. Recombination Analysis of Herpes Simplex Virus 1 Reveals a Bias toward GC Content and the Inverted Repeat Regions. Journal of Virology. 89: 7214-23. PMID 25926637 DOI: 10.1128/Jvi.00880-15  0.367
2015 Kolb AW, Larsen IV, Cuellar JA, Brandt CR. Genomic, phylogenetic, and recombinational characterization of herpes simplex virus 2 strains. Journal of Virology. 89: 6427-34. PMID 25855744 DOI: 10.1128/Jvi.00416-15  0.386
2015 Slauson SR, Peters DM, Schwinn MK, Kaufman PL, Gabelt BT, Brandt CR. Viral Vector Effects on Exoenzyme C3 Transferase-Mediated Actin Disruption and on Outflow Facility. Investigative Ophthalmology & Visual Science. 56: 2431-8. PMID 25783606 DOI: 10.1167/Iovs.14-15909  0.353
2014 Brandt CR. Peptide therapeutics for treating ocular surface infections. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 30: 691-9. PMID 25250986 DOI: 10.1089/Jop.2014.0089  0.421
2014 Sauter MM, Gauger JJ, Brandt CR. Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps. Antiviral Research. 109: 83-96. PMID 24995383 DOI: 10.1016/J.Antiviral.2014.06.015  0.467
2013 Kolb AW, Ané C, Brandt CR. Using HSV-1 genome phylogenetics to track past human migrations. Plos One. 8: e76267. PMID 24146849 DOI: 10.1371/Journal.Pone.0076267  0.324
2013 Cardozo FT, Larsen IV, Carballo EV, Jose G, Stern RA, Brummel RC, Camelini CM, Rossi MJ, Simões CM, Brandt CR. In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide. Antimicrobial Agents and Chemotherapy. 57: 2541-9. PMID 23507287 DOI: 10.1128/Aac.02250-12  0.768
2013 Jose GG, Larsen IV, Gauger J, Carballo E, Stern R, Brummel R, Brandt CR. A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo. Investigative Ophthalmology & Visual Science. 54: 1070-9. PMID 23341013 DOI: 10.1167/Iovs.12-10250  0.812
2012 Altmann SE, Brandt CR, Jahrling PB, Blaney JE. Antiviral activity of the EB peptide against zoonotic poxviruses. Virology Journal. 9: 6. PMID 22225618 DOI: 10.1186/1743-422X-9-6  0.831
2012 Berdugo M, Larsen IV, Abadie C, Deloche C, Kowalczuk L, Touchard E, Dubielzig R, Brandt CR, Behar-Cohen F, Combette JM. Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized anti-herpes simplex virus IgG Fab fragment following topical application. Antimicrobial Agents and Chemotherapy. 56: 1390-402. PMID 22203590 DOI: 10.1128/Aac.05145-11  0.459
2011 Kolb AW, Adams M, Cabot EL, Craven M, Brandt CR. Multiplex sequencing of seven ocular herpes simplex virus type-1 genomes: phylogeny, sequence variability, and SNP distribution. Investigative Ophthalmology & Visual Science. 52: 9061-73. PMID 22016062 DOI: 10.1167/Iovs.11-7812  0.344
2011 Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine. Vaccine. 29: 7696-703. PMID 21839131 DOI: 10.1016/J.Vaccine.2011.07.133  0.413
2011 Kolb AW, Schmidt TR, Dyer DW, Brandt CR. Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant. Investigative Ophthalmology & Visual Science. 52: 4630-8. PMID 21519032 DOI: 10.1167/Iovs.10-7032  0.393
2011 Altmann S, Brandt CR, Murphy CJ, Patnaikuni R, Takla T, Toomey M, Nesbit B, McIntyre K, Covert J, Dubielzig R, Leatherberry G, Adkins E, Kodihalli S. Evaluation of therapeutic interventions for vaccinia virus keratitis. The Journal of Infectious Diseases. 203: 683-90. PMID 21278209 DOI: 10.1093/Infdis/Jiq103  0.806
2011 Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. Identification of the minimal active sequence of an anti-influenza virus peptide. Antimicrobial Agents and Chemotherapy. 55: 1810-3. PMID 21220525 DOI: 10.1128/Aac.01428-10  0.528
2010 Larsen IV, Brandt CR. A cationic TAT peptide inhibits Herpes simplex virus type 1 infection of human corneal epithelial cells. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 26: 541-7. PMID 21029018 DOI: 10.1089/Jop.2010.0076  0.584
2010 Bultmann H, Girdaukas G, Kwon GS, Brandt CR. The virucidal EB peptide protects host cells from herpes simplex virus type 1 infection in the presence of serum albumin and aggregates proteins in a detergent-like manner. Antimicrobial Agents and Chemotherapy. 54: 4275-89. PMID 20643896 DOI: 10.1128/Aac.00495-10  0.493
2010 Altmann S, Emanuel A, Toomey M, McIntyre K, Covert J, Dubielzig RR, Leatherberry G, Murphy CJ, Kodihalli S, Brandt CR. A quantitative rabbit model of vaccinia keratitis. Investigative Ophthalmology & Visual Science. 51: 4531-40. PMID 20375331 DOI: 10.1167/Iovs.09-5106  0.813
2010 Altmann S, Toomey M, Nesbit B, McIntyre K, Covert J, Dubielzig RR, Leatherberry G, Adkins E, Murphy CJ, Brandt CR. Kinetics of immune cell infiltration in vaccinia virus keratitis. Investigative Ophthalmology & Visual Science. 51: 4541-8. PMID 20375330 DOI: 10.1167/Iovs.09-5107  0.801
2010 Lee ES, Gabelt BT, Faralli JA, Peters DM, Brandt CR, Kaufman PL, Bhattacharya SK. COCH transgene expression in cultured human trabecular meshwork cells and its effect on outflow facility in monkey organ cultured anterior segments. Investigative Ophthalmology & Visual Science. 51: 2060-6. PMID 19933177 DOI: 10.1167/Iovs.09-4521  0.302
2009 Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR. Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide. Virology. 388: 248-59. PMID 19395056 DOI: 10.1016/J.Virol.2009.03.023  0.842
2009 Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR. Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection. Antimicrobial Agents and Chemotherapy. 53: 987-96. PMID 19104014 DOI: 10.1128/Aac.00793-08  0.807
2008 Akkarawongsa R, Potocky TB, English EP, Gellman SH, Brandt CR. Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides. Antimicrobial Agents and Chemotherapy. 52: 2120-9. PMID 18391029 DOI: 10.1128/Aac.01424-07  0.798
2008 Cai S, Brandt CR. Induction of interleukin-6 in human retinal epithelial cells by an attenuated Herpes simplex virus vector requires viral replication and NFkappaB activation. Experimental Eye Research. 86: 178-88. PMID 18061164 DOI: 10.1016/J.Exer.2007.10.008  0.406
2007 Brandt CR, Akkarawongsa R, Altmann S, Jose G, Kolb AW, Waring AJ, Lehrer RI. Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis. Investigative Ophthalmology & Visual Science. 48: 5118-24. PMID 17962464 DOI: 10.1167/Iovs.07-0302  0.723
2007 Bultmann H, Teuton J, Brandt CR. Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain. Antimicrobial Agents and Chemotherapy. 51: 1596-607. PMID 17261627 DOI: 10.1128/Aac.01009-06  0.835
2007 Teuton JR, Brandt CR. Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells. Journal of Virology. 81: 3731-9. PMID 17229687 DOI: 10.1128/Jvi.02250-06  0.796
2007 Jones J, Brandt CR, Schultz-Cherry S. Influenza defense: Expanding our arsenal with peptide antivirals Future Virology. 2: 231-233. DOI: 10.2217/17460794.2.3.231  0.361
2006 Jones JC, Turpin EA, Bultmann H, Brandt CR, Schultz-Cherry S. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. Journal of Virology. 80: 11960-7. PMID 17005658 DOI: 10.1128/Jvi.01678-06  0.544
2006 Akkarawongsa R, Cullinan AE, Zinkel A, Clarin J, Brandt CR. Corneal toxicity of cell-penetrating peptides that inhibit Herpes simplex virus entry. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 22: 279-89. PMID 16910869 DOI: 10.1089/Jop.2006.22.279  0.751
2005 Brandt CR. The role of viral and host genes in corneal infection with herpes simplex virus type 1. Experimental Eye Research. 80: 607-21. PMID 15862167 DOI: 10.1016/J.Exer.2004.09.007  0.432
2004 Cullinan AE, Lindstrom MJ, Sabet S, Albert DM, Brandt CR. Evaluation of the antitumor effects of Herpes simplex virus lacking ribonucleotide reductase in a murine retinoblastoma model. Current Eye Research. 29: 167-72. PMID 15512963 DOI: 10.1080/02713680490504894  0.814
2004 Brandt CR. Virulence genes in herpes simplex virus type 1 corneal infection. Current Eye Research. 29: 103-17. PMID 15512957 DOI: 10.1080/02713680490504533  0.497
2004 Cullinan AE, Brandt CR. Cytokine induced apoptosis in human retinoblastoma cells. Molecular Vision. 10: 315-22. PMID 15133451  0.743
2004 Kolb AW, Brandt CR. Enhanced isolation of low frequency herpes simplex virus recombinants using green-fluorescent protein and FACS. Journal of Virological Methods. 115: 73-81. PMID 14656463 DOI: 10.1016/J.Jviromet.2003.09.017  0.447
2003 Brandt CR, Kolb AW. Tyrosine 116 of the herpes simplex virus type 1 IEalpha22 protein is an ocular virulence determinant and potential phosphorylation site. Investigative Ophthalmology & Visual Science. 44: 4601-7. PMID 14578374 DOI: 10.1167/Iovs.03-0582  0.365
2003 Brandt CR, Kolb AW, Shah DD, Pumfery AM, Kintner RL, Jaehnig E, Van Gompel JJ. Multiple determinants contribute to the virulence of HSV ocular and CNS infection and identification of serine 34 of the US1 gene as an ocular disease determinant. Investigative Ophthalmology & Visual Science. 44: 2657-68. PMID 12766070 DOI: 10.1167/Iovs.02-1105  0.379
2003 Spear MA, Schuback D, Miyata K, Grandi P, Sun F, Yoo L, Nguyen A, Brandt CR, Breakefield XO. HSV-1 amplicon peptide display vector. Journal of Virological Methods. 107: 71-9. PMID 12445940 DOI: 10.1016/S0166-0934(02)00193-3  0.504
2002 Liu X, Huang CY, Cai S, Polansky JR, Kaufman PL, Brandt CR. Transformation of human trabecular meshwork cells with SV40 TAg alters promoter utilization. Current Eye Research. 25: 347-53. PMID 12789541 DOI: 10.1076/Ceyr.25.6.347.14226  0.334
2002 Bultmann H, Brandt CR. Peptides containing membrane-transiting motifs inhibit virus entry. The Journal of Biological Chemistry. 277: 36018-23. PMID 12130644 DOI: 10.1074/Jbc.M204849200  0.524
2002 Visalli RJ, Brandt CR. Mutation of the herpes simplex virus 1 KOS UL45 gene reveals dose dependent effects on central nervous system growth. Archives of Virology. 147: 519-32. PMID 11958453 DOI: 10.1007/S007050200004  0.459
2001 Spencer B, Agarwala S, Gentry L, Brandt CR. HSV-1 vector-delivered FGF2 to the retina is neuroprotective but does not preserve functional responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 746-56. PMID 11356079 DOI: 10.1006/Mthe.2001.0307  0.38
2001 Bultmann H, Busse JS, Brandt CR. Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1. Journal of Virology. 75: 2634-45. PMID 11222686 DOI: 10.1128/Jvi.75.6.2634-2645.2001  0.59
2000 Piraino F, Brandt CR. Isolation and partial characterization of an antiviral, RC-183, from the edible mushroom Rozites caperata. Antiviral Research. 43: 67-78. PMID 10517309 DOI: 10.1016/S0166-3542(99)00035-2  0.588
1999 Liu X, Brandt CR, Gabelt BT, Bryar PJ, Smith ME, Kaufman PL. Herpes simplex virus mediated gene transfer to primate ocular tissues. Experimental Eye Research. 69: 385-95. PMID 10504272 DOI: 10.1006/Exer.1999.0711  0.433
1997 Brandt CR, Imesch P, Spencer B, Eliassi-Rad B, Syed NA, Untawale S, Robinson NL, Albert DM. The herpes simplex virus type 1 ribonucleotide reductase is required for acute retinal disease. Archives of Virology. 142: 883-96. PMID 9191855 DOI: 10.1007/S007050050126  0.411
1997 Brandt CR, Imesch PD, Robinson NL, Syed NA, Untawale S, Darjatmoko SR, Chappell RJ, Heinzelman P, Albert DM. Treatment of spontaneously arising retinoblastoma tumors in transgenic mice with an attenuated herpes simplex virus mutant Virology. 229: 283-291. PMID 9123872 DOI: 10.1006/Viro.1996.8414  0.381
1996 Pumfery AM, Brandt CR. Thymidine kinase and susceptibility to interferon are not involved in the increased virulence of recombinant viruses isolated following mixed ocular infection with HSV strains OD4 and CJ394. Ophthalmic Research. 28: 125-9. PMID 8792363 DOI: 10.1159/000267884  0.469
1996 Peters DM, Dowd N, Brandt C, Compton T. Human papilloma virus E6/E7 genes can expand the lifespan of human corneal fibroblasts In Vitro Cellular and Developmental Biology - Animal. 32: 279-284. PMID 8792157 DOI: 10.1007/Bf02723060  0.335
1996 Brandt CR, Spencer B, Imesch P, Garneau M, Déziel R. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease. Antimicrobial Agents and Chemotherapy. 40: 1078-84. PMID 8723444 DOI: 10.1128/Aac.40.5.1078  0.555
1995 Kintner RL, Brandt CR. Rapid small-scale isolation of herpes simplex virus DNA. Journal of Virological Methods. 48: 189-96. PMID 7989436 DOI: 10.1016/0166-0934(94)90118-X  0.353
1995 Kintner RL, Brandt CR. The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection. Current Eye Research. 14: 145-52. PMID 7768106 DOI: 10.3109/02713689508999926  0.38
1995 Banfield BW, Leduc Y, Esford L, Visalli RJ, Brandt CR, Tufaro F. Evidence for an Interaction of Herpes Simplex Virus with Chondroitin Sulfate Proteoglycans during Infection Virology. 208: 531-539. PMID 7747425 DOI: 10.1006/Viro.1995.1184  0.42
1995 Kintner RL, Allan RW, Brandt CR. Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains. Archives of Virology. 140: 231-44. PMID 7710352 DOI: 10.1007/Bf01309859  0.402
1995 Abrams ME, Balish MJ, Brandt CR. IFN-alpha induces MxA gene expression in cultured human corneal fibroblasts. Experimental Eye Research. 60: 137-42. PMID 7540146 DOI: 10.1016/S0014-4835(95)80003-4  0.326
1994 Herold BC, Visalli RJ, Susmarski N, Brandt CR, Spear PG. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. The Journal of General Virology. 1211-22. PMID 8207388 DOI: 10.1099/0022-1317-75-6-1211  0.441
1993 Visalli RJ, Brandt CR. The HSV-1 UL45 18 kDa gene product is a true late protein and a component of the virion. Virus Research. 29: 167-78. PMID 8212858 DOI: 10.1016/0168-1702(93)90057-T  0.357
1993 Brandt CR. Susceptibility of +/+, +/nu and nu/nu BALB/c mice to ocular herpes simplex virus infection. Ophthalmic Research. 24: 332-7. PMID 1287512 DOI: 10.1159/000267189  0.327
1992 Brandt CR. Mixed ocular infections identify strains of herpes simplex virus for use in genetic studies. Journal of Virological Methods. 35: 127-35. PMID 1667784 DOI: 10.1016/0166-0934(91)90128-M  0.421
1992 Brandt CR, Coakley LM, Grau DR. A murine model of herpes simplex virus-induced ocular disease for antiviral drug testing. Journal of Virological Methods. 36: 209-22. PMID 1560105 DOI: 10.1016/0166-0934(92)90052-F  0.483
1992 Balish MJ, Abrams ME, Pumfery AM, Brandt CR. Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and -gamma. The Journal of Infectious Diseases. 166: 1401-3. PMID 1331251 DOI: 10.1093/Infdis/166.6.1401  0.443
1991 Visalli RJ, Brandt CR. The HSV-1 UL45 gene product is not required for growth in Vero cells. Virology. 185: 419-23. PMID 1656593 DOI: 10.1016/0042-6822(91)90790-I  0.37
1991 Brandt CR, Kintner RL, Pumfery AM, Visalli RJ, Grau DR. The herpes simplex virus ribonucleotide reductase is required for ocular virulence. The Journal of General Virology. 2043-9. PMID 1654368 DOI: 10.1099/0022-1317-72-9-2043  0.483
Show low-probability matches.